BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 24362683)

  • 1. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
    Nokes DJ; Okiro EA; Ngama M; Ochola R; White LJ; Scott PD; English M; Cane PA; Medley GF
    Clin Infect Dis; 2008 Jan; 46(1):50-7. PubMed ID: 18171213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus and reactive airway disease.
    Lotz MT; Moore ML; Peebles RS
    Curr Top Microbiol Immunol; 2013; 372():105-18. PubMed ID: 24362686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
    Munoz FM
    Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus infections: old challenges and new opportunities.
    Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses and disease enhancement during respiratory syncytial virus infection.
    Openshaw PJ; Tregoning JS
    Clin Microbiol Rev; 2005 Jul; 18(3):541-55. PubMed ID: 16020689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
    Browne SK; Beeler JA; Roberts JN
    Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Load in Infants Hospitalized for Respiratory Syncytial Virus Bronchiolitis Correlates with Recurrent Wheezing at Thirty-Six-Month Follow-Up.
    Nenna R; Ferrara M; Nicolai A; Pierangeli A; Scagnolari C; Papoff P; Antonelli G; Moretti C; Midulla F
    Pediatr Infect Dis J; 2015 Oct; 34(10):1131-2. PubMed ID: 26132826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in and the potential of vaccines for respiratory syncytial virus.
    Jorquera PA; Oakley KE; Tripp RA
    Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with respiratory syncytial virus vaccines.
    Piedra PA
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers.
    Haynes AK; Manangan AP; Iwane MK; Sturm-Ramirez K; Homaira N; Brooks WA; Luby S; Rahman M; Klena JD; Zhang Y; Yu H; Zhan F; Dueger E; Mansour AM; Azazzy N; McCracken JP; Bryan JP; Lopez MR; Burton DC; Bigogo G; Breiman RF; Feikin DR; Njenga K; Montgomery J; Cohen AL; Moyes J; Pretorius M; Cohen C; Venter M; Chittaganpitch M; Thamthitiwat S; Sawatwong P; Baggett HC; Luber G; Gerber SI
    J Infect Dis; 2013 Dec; 208 Suppl 3():S246-54. PubMed ID: 24265484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
    Tang RS; MacPhail M; Schickli JH; Kaur J; Robinson CL; Lawlor HA; Guzzetta JM; Spaete RR; Haller AA
    J Virol; 2004 Oct; 78(20):11198-207. PubMed ID: 15452239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus.
    Stensballe LG; Devasundaram JK; Simoes EA
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S21-32. PubMed ID: 12671449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.
    Groothuis JR; Hoopes JM; Jessie VG
    Adv Ther; 2011 Feb; 28(2):91-109. PubMed ID: 21318606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.